The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.